Regional Analysis of the HER2 Antibodies Market: Focus on North America 2034
The HER2 antibodies industry continues to gain momentum as targeted cancer therapies become increasingly important in modern oncology treatment protocols. Growing prevalence of HER2-positive cancers, especially breast and gastric cancers, has accelerated the adoption of advanced biologic therapies across developed and emerging healthcare systems. Pharmaceutical companies and biotechnology...
0 Comments 0 Shares 10 Views 0 Reviews